China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S. 
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement 
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance 
Google Secures Pentagon AI Deal for Classified Projects 
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings 
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat 
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges 
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance 
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth 
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue 
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector 
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth 
Shares in SK Corp. took a six percent hike Wednesday after announcing plans to list its subsidiary SK Biopharmaceuticals to raise 959.3 billion won.
It will be South Korea's biggest stock market debut since May 2017, when mobile gaming firm Netmarble raised 2.7 trillion won.
SK Biopharmaceuticals' anti-epilepsy drug, Cenobamate, began to sell in the US this month after the US Food and Drug Administration approved it in November.
The company will sell about 25 percent of its shares, with the final pricing of the share offering expected to on June 18.
Mirae Asset Daewoo Securities analyst Chung Dae-ro projects the company's market value to reach five trillion won.
After the Covid-19 pandemic pushed South Korean companies to postpone listing plans, many smaller companies in the country are now preparing to go public as the health situation improves.
An investment banker noted that the mood has changed since April as the stock market recovers.
South Korea's benchmark Kospi stock index has increased by more than a third since March.
Other companies expected to go public this year include Big Hit, the music label behind South Korean boy band BTS, which is eyeing to raise nearly around 1.226 trillion won.
There's also Hyundai Card, the credit card unit of Hyundai Motor Group, which is preparing a 2.45 trillion won listing.
